← Leaderboards
Caren L. Freel Meyers
Johns Hopkins University
$14,512,343
Attributed
$18,126,450
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,126,450 · 9
By mechanism
R01$12,970,013 · 5
T32$4,070,440 · 2
R56$640,497 · 1
R21$445,500 · 1
Top collaborators
- Steve Rannard5 shared
- Andrew Owen4 shared
- Henry Lee Woodcock Iii4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Solomon H Snyder$44,504,082
- Andrew Owen$1,238,957
- Thao D Nguyen$1,751,374
- Steven M Chase$2,929,371
- Carlos Alberto Tristan$126,264
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPharmacologyInsightEnzymesDiphosphatesPathogenIsoprenoidAnalogInfectionReactionLeadBaseDrug ResistanceMolecularInorganic PhosphateAnabolismPathway InteractionsAntimicrobialInterestMetabolismChemistryCollaborationsIn VivoProdrugs
Grant awards (43)
Pharmacology and Molecular Sciences Training Program$478,905
T32 · FY2025 · GM · contact PI
Targeting DXP synthase in bacterial metabolism$453,810
R01 · FY2025 · AI · contact PI
Targeting DXP synthase in bacterial metabolism$576,194
R01 · FY2024 · AI · contact PI
Toward understanding the chemistry and biology of microbial DXP synthase$398,904
R01 · FY2024 · GM · contact PI
Pharmacology and Molecular Sciences Training Program$396,918
T32 · FY2024 · GM · contact PI
Targeting DXP synthase in bacterial metabolism$576,194
R01 · FY2023 · AI · contact PI
Pharmacology and Molecular Sciences Training Program$477,482
T32 · FY2023 · GM · contact PI
Toward understanding the chemistry and biology of microbial DXP synthase$403,270
R01 · FY2023 · GM · contact PI
Targeting DXP synthase in bacterial metabolism$576,194
R01 · FY2022 · AI · contact PI
Pharmacology and Molecular Sciences Training Program$468,325
T32 · FY2022 · GM · contact PI
Toward understanding the chemistry and biology of microbial DXP synthase$398,904
R01 · FY2022 · GM · contact PI
Pharmacology and Molecular Sciences Training Program: Enhancing Inclusivity Through Universal Design for Learning in Graduate Courses$86,264
T32 · FY2022 · GM · contact PI
Long acting NRTI therapies for HIV$549,842
R01 · FY2021 · AI · contact PI
Targeting DXP synthase in bacterial metabolism$547,594
R01 · FY2021 · AI · contact PI
Toward understanding the chemistry and biology of microbial DXP synthase$444,006
R01 · FY2021 · GM · contact PI
Pharmacology and Molecular Sciences Training Program$438,866
T32 · FY2021 · GM · contact PI
Toward targeting bacterial metabolism: Relevance, mechanism and function of DXP synthase$640,497
R56 · FY2020 · AI · contact PI
Long acting NRTI therapies for HIV$609,668
R01 · FY2020 · AI · contact PI
Pharmacology and Molecular Sciences Training Program$433,850
T32 · FY2020 · GM · contact PI
Long acting NRTI therapies for HIV$670,898
R01 · FY2019 · AI · contact PI
Pharmacology Training Grant$310,897
T32 · FY2019 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$106,438
R01 · FY2019 · GM · contact PI
Long acting NRTI therapies for HIV$619,020
R01 · FY2018 · AI · contact PI
Pharmacology Training Grant$329,909
T32 · FY2018 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$321,772
R01 · FY2018 · GM · contact PI
Long acting NRTI therapies for HIV$655,789
R01 · FY2017 · AI · contact PI
Towards complete sustained release nanoformulations of NRTI based regimens$557,845
R01 · FY2017 · AI · contact PI
Pharmacology Training Grant$326,281
T32 · FY2017 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$321,772
R01 · FY2017 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$27,659
R01 · FY2017 · GM · contact PI
Towards complete sustained release nanoformulations of NRTI based regimens$622,001
R01 · FY2016 · AI · contact PI
Pharmacology Training Grant$322,743
T32 · FY2016 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$321,772
R01 · FY2016 · GM · contact PI
Towards complete sustained release nanoformulations of NRTI based regimens$635,790
R01 · FY2015 · AI · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$337,272
R01 · FY2015 · GM · contact PI
Towards complete sustained release nanoformulations of NRTI based regimens$662,278
R01 · FY2014 · AI · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$316,602
R01 · FY2014 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$305,521
R01 · FY2013 · GM · contact PI
Membrane Permeable Diphosphate Analogs Targeting Pathogen Isoprenoid Biosynthesis$202,500
R21 · FY2013 · AI · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$316,602
R01 · FY2012 · GM · contact PI
Membrane Permeable Diphosphate Analogs Targeting Pathogen Isoprenoid Biosynthesis$243,000
R21 · FY2012 · AI · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$316,602
R01 · FY2011 · GM · contact PI
Targeting Non-mammalian Isoprenoid Biosynthesis$319,800
R01 · FY2010 · GM · contact PI